| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.006 |